Popular weight loss drugs Ozempic and Wegovy have been linked to significant gastrointestinal problems in a handful of patients, according to new research published on Thursday in the Journal of the American Medical Association.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.